Revenue and Profitability - Revenue for Q3 2022 was CNY 56,190,689.06, a decrease of 5.17% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was CNY 23,581,323.57, an increase of 96.01% year-on-year[5] - Basic earnings per share for Q3 2022 was CNY 0.30, up 57.89% from the previous year[5] - The total revenue for the first nine months of 2022 reached ¥133,587,568.81, representing a 31.14% increase compared to ¥101,868,345.82 in the same period of 2021[9] - Net profit for the current period was ¥46,859,073.81, representing a 50.3% increase from ¥31,180,641.70 in the same period last year[20] - Operating profit increased to ¥55,147,550.67, a rise of 43.3% compared to ¥38,525,397.05 in the previous period[20] - The company anticipates continued growth in revenue and profitability as it expands its business operations and product offerings[9] Assets and Equity - Total assets as of September 30, 2022, reached CNY 1,378,454,488.30, a 157.26% increase from the end of the previous year[5] - The company’s total equity attributable to shareholders increased by 238.74% to CNY 1,213,511,171.90 compared to the end of the previous year[5] - As of September 30, 2022, the total assets of Xi'an Xice Testing Technology Co., Ltd. amounted to CNY 1,378,454,488.30, a significant increase from CNY 535,825,803.96 at the beginning of the year[16] - The company's current assets reached CNY 1,192,327,776.99, up from CNY 347,267,480.81 at the start of the year, indicating strong liquidity growth[16] - The equity attributable to shareholders of the parent company increased to CNY 1,213,511,171.90 from CNY 358,237,418.99, showcasing substantial growth in shareholder value[18] Cash Flow and Financial Management - The company reported a cash flow deficit from operating activities of CNY -10,911,308.01, a 57.37% increase in outflow compared to the previous year[5] - Cash and cash equivalents rose to CNY 688,914,456.39 from CNY 51,233,989.07, highlighting a significant improvement in cash flow management[16] - Cash flow from operating activities showed a net outflow of ¥10,911,308.01, an improvement from a net outflow of ¥25,597,353.38 in the prior period[21] - Total cash inflow from financing activities was ¥878,437,456.75, a substantial increase from ¥44,060,898.23 in the previous period, highlighting strong capital raising efforts[22] Expenses and Costs - Research and development expenses for the first nine months of 2022 were CNY 11,016,374.49, reflecting a 52.87% increase due to enhanced innovation efforts[8] - Total operating costs amounted to ¥141,692,907.58, up 20.2% from ¥117,804,138.20 in the prior period[19] - The company reported a significant increase in R&D expenses, which rose to ¥11,016,374.49, compared to ¥7,206,259.23 in the previous period, reflecting a focus on innovation[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,208, with no preferred shareholders[11] - The largest shareholder, Li Zexin, holds 41.23% of the company's shares, totaling 34,800,000 shares[11] - The total number of restricted shares remained unchanged at 64,389,973, indicating no new restrictions or releases during the reporting period[14] Government Support and Other Income - The company received government subsidies amounting to CNY 18,274,054.36 during the reporting period, contributing to its financial performance[6] - Other income increased significantly by 502.19% to ¥23,635,544.98, primarily due to government subsidies received after the company's listing[9] - Cash received from tax refunds surged by 5471.71% to ¥818,606.50, attributed to policy changes regarding the refund of input VAT[9] Liabilities and Financial Stability - The total liabilities decreased to CNY 160,524,031.32 from CNY 176,466,785.27, reflecting improved financial stability[17] - The company reported a decrease in short-term borrowings to CNY 19,957,400.00 from CNY 40,318,380.10, suggesting a reduction in reliance on debt financing[17]
西测测试(301306) - 2022 Q3 - 季度财报